Evidence map›Paper›PMID 32499698›Full record

ArticleFrontiers in pharmacology2020

Andersen-Tawil Syndrome Is Associated With Impaired PIP

Reem Handklo-Jamal, Eshcar Meisel, Daniel Yakubovich, Leonid Vysochek, Roy Beinart, Michael Glikson, Julie R McMullen, Nathan Dascal, Eyal Nof, Shimrit Oz

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. The network of cardiac KNaunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  8. Extracellular Kir2.1Circulation research · 2024
    Article
  9. Article
  10. Extracellular cysteine disulfide bond break at Cys122 disrupts PIPbioRxiv : the preprint server for biology · 2023
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Characterization of Loss-Of-FunctionFrontiers in genetics · 2021
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Reem Handklo-JamalSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Eshcar MeiselSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Daniel YakubovichSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Leonid VysochekHeart Center, Sheba Medical Center, Ramat-Gan, Israel.
Roy BeinartSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Michael GliksonSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Julie R McMullenBaker Heart and Diabetes Institute, Melbourne, VIC, Australia.
Nathan DascalSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Eyal NofSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Shimrit OzSackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Sheba Medical Center · ILTel Aviv University · ILBaker Heart and Diabetes Institute · AUSchneider Children's Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Andersen-Tawil syndrome (ATS) type-1 is associated with loss-of-function mutations in

Indexed as

Andersen–Tawil syndromeBGP-15cardiac arrhythmiaG-loopinward-rectifier potassium channelPIP2slide helixvoltage-sensitive phosphatase

Identifiers

PMID32499698
PMCPMC7243181
OpenAlexW3025987403

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.